These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 994932)

  • 21. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.
    Willerson JT; Thompson RH; Hookman P; Herdt J; Decker JL
    Ann Intern Med; 1970 Jan; 72(1):17-27. PubMed ID: 5410395
    [No Abstract]   [Full Text] [Related]  

  • 22. Reserpine and Raynaud's phenomenon.
    Gifford RW
    N Engl J Med; 1971 Jul; 285(5):290-1. PubMed ID: 5090401
    [No Abstract]   [Full Text] [Related]  

  • 23. The diagnosis and treatment of Raynaud's phenomenon.
    Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR
    Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spasm and Raynaud's phenomenon].
    Fiessinger JN
    Ann Cardiol Angeiol (Paris); 1981; 30(2):91-3. PubMed ID: 7259052
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interstitialis calcinosis in Raynaud's disease].
    SANDER
    Dtsch Gesundheitsw; 1956 Oct; 11(41):1378-84. PubMed ID: 13375205
    [No Abstract]   [Full Text] [Related]  

  • 26. Reserpine in Raynaud's phenomenon.
    Lancet; 1970 Aug; 2(7670):454. PubMed ID: 4195127
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral L-arginine can reverse digital necrosis in Raynaud's phenomenon.
    Rembold CM; Ayers CR
    Mol Cell Biochem; 2003 Feb; 244(1-2):139-41. PubMed ID: 12701823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematemesis after reserpine for Raynaud's phenomenon.
    Sharon E; Paolino JS; Kaplan D
    Ann Intern Med; 1972 Sep; 77(3):479-80. PubMed ID: 5053741
    [No Abstract]   [Full Text] [Related]  

  • 29. Arthritis mutilans, tumoral calcinosis, Raynaud's phenomenon and Sjögren's syndrome.
    Monteagudo M; Lima J; Bravo ML; García-Bragado F; Lience E; Vilardell M; Arnal MC
    Br J Rheumatol; 1990 Aug; 29(4):303-5. PubMed ID: 2379048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case report on the CRST-syndrome. (Calcinosis cutis, Raynaud's phenomenon, sclerodactylia, telangiectasia)].
    Pöhler H; Zipfel K
    Dermatol Monatsschr; 1972 Sep; 158(9):660-5. PubMed ID: 4643804
    [No Abstract]   [Full Text] [Related]  

  • 31. Myxoedema and Raynaud's phenomenon.
    Nielsen SL; Parving HH; Hansen JE
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):32-4. PubMed ID: 7124291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raynaud's disease presenting in a 5-month-old-male infant.
    Sayre JW
    Pediatrics; 1973 Sep; 52(3):412-5. PubMed ID: 4730398
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcinosis circumscripta: case report and review.
    Cohen SJ
    J Foot Surg; 1980; 19(4):190-2. PubMed ID: 7264227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystrophic calcifications and Raynaud's phenomenon in an eight-year old girl.
    Grebeldinger SP; Tomić JM; Vijatov-Djurić GV; Radojcić BS; Vucković NM; Culafić JN
    Srp Arh Celok Lek; 2014; 142(3-4):239-42. PubMed ID: 24839783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
    Kahan A; Amor B; Menkes CJ
    Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial calcinosis and scleroderma associated with rheumatoid arthritis and Raynaud's disease.5A case report.
    Sherman BD
    J Am Podiatry Assoc; 1968 Feb; 58(2):68-71. PubMed ID: 5636488
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacologic management of Raynaud's phenomenon.
    Day TW; Mendoza F
    South Med J; 1984 Sep; 77(9):1160-4. PubMed ID: 6385288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of diltiazem on calcinosis in a patient with the CREST syndrome.
    Farah MJ; Palmieri GM; Sebes JI; Cremer MA; Massie JD; Pinals RS
    Arthritis Rheum; 1990 Aug; 33(8):1287-93. PubMed ID: 2390132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.